Houston Methodist

Running trials

• Not yet recruiting

  Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer

  NCT07796490· Phase 1/2· Source

• Not yet recruiting

  A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

  NCT06458907· Source

• Enrolling by invitation

  Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

  NCT07197788· Source

• Recruiting

  Stem Cells for Erectile Dysfunction Post RALP

  NCT07048314· Phase 1/2· Source

• Recruiting

  Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  NCT07195591· Phase 3· Source

• Recruiting

  Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  NCT06906627· Source

• Recruiting

  Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  NCT06906640· Source

• Recruiting

  Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

  NCT07182279· Phase 1/2· Source

• Recruiting

  Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

  NCT06898515· Source

• Recruiting

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· Source

• Active, not recruiting

  VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

  NCT06249165· Phase 4· Source

• Recruiting

  Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  NCT06526195· Source

• Recruiting

  Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

  NCT06833866· Phase 1· Source

• Recruiting

  Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  NCT06567743· Phase 2· Source

• Active, not recruiting

  TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

  NCT06137807· Source

• Recruiting

  PRESSURE CHECK: Find Your Path to Better Health

  NCT06122246· Source

• Recruiting

  A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

  NCT06072781· Phase 3· Source

• Enrolling by invitation

  Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

  NCT06052072· Source

• Active, not recruiting

  An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  NCT06129240· Source

• Recruiting

  A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  NCT05710848· Phase 1/2· Source

• Active, not recruiting

  A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

  NCT05926765· Phase 2· Source

• Active, not recruiting

  Assessment of Combined CCM and ICD Device in HFrEF

  NCT05855135· Source

• Active, not recruiting

  Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

  NCT05611931· Phase 3· Source

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· Source

• Recruiting

  Assessment of CCM in HF With Higher Ejection Fraction

  NCT05064709· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Active, not recruiting

  SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

  NCT05198674· Source

• Recruiting

  Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  NCT04634916· Source

• Active, not recruiting

  ROSE-Longitudinal Assessment With Neuroimaging

  NCT05089331· Source

• Recruiting

  Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  NCT04575935· Phase 3· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Source

• Active, not recruiting

  PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

  NCT04089059· Source

• Active, not recruiting

  Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

  NCT03108456· Source

• Active, not recruiting

  Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

  NCT02181257· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure5 recruiting
• High blood pressure4 recruiting
• Chronic kidney disease3 recruiting
• Prostate cancer3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Type 2 diabetes3 recruiting
• Bladder cancer2 recruiting
• Ovarian cancer2 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Glioblastoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Source

• Completed

  Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS

  NCT07095712· Phase 1/2· Source

• Completed

  Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

  NCT06089135· Source

• Completed

  A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

  NCT05383170· Phase 1/2· Source

• Completed

  A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

  NCT05425056· Phase 3· Source

• Terminated

  Open-Label Surufatinib in European Patients With NET

  NCT04579679· Phase 2· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Source

• Completed

  SVC Occlusion in Subjects With Acute Decompensated Heart Failure

  NCT03836079· Source

• Completed

  Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

  NCT03837327· Source

• Completed

  Recovery and Outcomes From Stroke

  NCT04007757· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source

• Completed

  HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  NCT01913106· Phase 1/2· Source